Related Experiment Video
Updated: May 17, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Synthetic MRI in Progressive MS: Associations with Disability
N Braga1, F X Aymerich2,3, J Alonso2
1From the Department of Neurology-Multiple Sclerosis Centre of Catalonia (Cemcat)(N.B., N.M.-O., X.M., A.V.-J., J.S.-G.), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Background And Purpose:
Synthetic MRI (SyMRI) is a short-time acquisition sequence that generates different contrast-weighted images based on the measurement of tissue properties and provides quantitative volumetric, relaxation, and myelin maps. It has been used as an alternative to conventional MRI sequences in relapsing-remitting MS for detecting focal lesions and volumetric analysis. This study aimed to find an SyMRI variable associated with an Expanded Disability Status Scale (EDSS) ≥ 6 in progressive patients.
Materials And Methods:
Twenty-four patients with progressive MS underwent SyMRI with a 2D axial QRAPMASTER pulse sequence. We analyzed volumetric parameters, global myelin fraction (MyCF), and quantitative values derived from maps of proton density, R1, R2, and myelin for the masks: normal-appearing white and gray matter, lesion, and corpus callosum. A t test compared SyMRI variables between groups, followed by univariate binary logistic regression for significant (P < .05) or trending results (P < .09).
Results:
Patients were categorized into 2 groups (EDSS < 6 versus ≥ 6). Variables with significant differences between groups were: brain parenchymal fraction (P = .05), white matter fraction (P = .05), MyCF (P = .04), and corpus callosum volume (P = .04). In the binary logistic regression analysis, the best predictor of the EDSS category was MyCF, with a P value of .08, and an OR of 0.59.
Conclusions:
Our results confirm differences in volumetric parameters by EDSS by using a single MRI acquisition. Additionally, higher MyCF values were associated with lower disability, highlighting SyMRI and myelin quantification as potential tools for clinical practice.

